Jenburkt Pharmaceuticals Share Price
Know More₹1,107.00 37.00 (3.46%)
04:01 PM, 13-Feb-2025BSE : 524731
NSE :
Sector : Health care
ISIN Code : INE354A01013
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 13-Feb-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 488 |
Traded Value (₹ Cr) | 0.07 |
Volume (Shares) | 597 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,375.00 |
52-Week High Date | 08-Nov-2024 |
52-Week Low (₹) | 660.05 |
52-Week Low Date | 14-Mar-2024 |
All Time High (₹) | 1,375.00 |
All Time High Date | 08-Nov-2024 |
All Time Low (₹) | 1.80 |
All Time Low Date | 11-Feb-1998 |
Jenburkt Pharmaceuticals Ltd
Market News
Jenburkt Pharma Announcement
Jenburkt Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 488 |
| EPS - TTM (₹) [S] | 71.16 |
| P/E Ratio (X) [S] | 15.56 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 153.00 |
| Latest Dividend Date | 23-Jul-2024 |
| Dividend Yield (%) | 1.40 |
| Book Value Share (₹) [S] | 357.47 |
| P/B Ratio (₹) [S] | 3.10 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 1,033.00 1,121.00 |
| Week Low/High (₹) | 975.00 1,174.00 |
| Month Low/High (₹) | 975.00 1,279.00 |
| Year Low/High (₹) | 660.05 1,375.00 |
| All time Low/High (₹) | 1.80 1,375.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -2.61% | % | -2.46 | -2.42% |
| 1 Month | -6.41% | % | -0.25 | -0.24% |
| 3 Month | -1.46% | % | -2.00 | -2.24% |
| 6 Month | 24.10% | % | -3.57 | -4.59% |
| 1 Year | 39.56% | % | 7.13 | 6.55% |
| 3 Year | 100.85% | % | 30.93 | 32.56% |
Company Info
Company Information
Company Sec. & Compli. Officer : Ashish R Shah
Chairman & Managing Director : Ashish U Bhuta
Whole Time Director & CFO : Dilip H Bhuta
Non-Exec. & Independent Dir. : Hina Ravindra Mehta
Independent Director : Sumit Ajaybhai Thakkar
Independent Director : KRISHNAN SUBHARAMAN
Independent Director : PANKAJ .
Registered Office: Nirmala Apartment P B No 37396, 93 Jayprakash Road Andheri(W),Mumbai,Maharashtra-400058 Ph: 91-22-66943121/67603603
Email:investor@jenburkt.com
FAQs about Jenburkt Pharmaceuticals Ltd
1. What's the Jenburkt Pharmaceuticals Ltd share price today?
Jenburkt Pharmaceuticals Ltd share price was Rs 1,107.00 at 04:01 PM IST on 13th Feb 2025. Jenburkt Pharmaceuticals Ltd share price was up by 3.46% over the previous closing price of Rs 1,070.00. Jenburkt Pharmaceuticals Ltd share price trend:
- Last 1 Month: Jenburkt Pharmaceuticals Ltd share price moved down by 6.41% on BSE
- Last 3 Months: Jenburkt Pharmaceuticals Ltd share price moved down by 1.46% on BSE
- Last 12 Months: Jenburkt Pharmaceuticals Ltd share price moved up by 39.56% on BSE
- Last 3 Years: Jenburkt Pharmaceuticals Ltd price moved up by 100.85% on BSE
2. How can I quickly analyse the performance of the Jenburkt Pharmaceuticals Ltd stock?
The performance of the Jenburkt Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 15.56
- Price to book value ratio is 3.10
- Dividend yield of 1.40
- The EPS (trailing 12 months) of the Jenburkt Pharmaceuticals Ltd stock is Rs 71.16
3. What is the market cap of Jenburkt Pharmaceuticals Ltd?
Jenburkt Pharmaceuticals Ltd has a market capitalisation of Rs 488 crore.
4. What is Jenburkt Pharmaceuticals Ltd's 52-week high/low share price?
The Jenburkt Pharmaceuticals Ltd’s 52-week high share price is Rs 1,375.00 and 52-week low share price is Rs 660.05.
5. Is the Jenburkt Pharmaceuticals Ltd profitable?
On a consolidated basis, Jenburkt Pharmaceuticals Ltd reported a profit of Rs 6.51 crore on a total income of Rs 38.47 crore for the quarter ended 2024. For the year ended Dec 2024, Jenburkt Pharmaceuticals Ltd had posted a profit of Rs 6.51 crore on a total income of Rs 38.47 crore.
6. Which are Jenburkt Pharmaceuticals Ltd’s peers in the Health care sector?
Jenburkt Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Albert David, Kilitch Drugs, Megasoft, Jenburkt Pharma, Zim Laboratories, Kerala Ayurveda, Titan Biotech.
7. Who owns how much in Jenburkt Pharmaceuticals Ltd?
Key changes to the Jenburkt Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Jenburkt Pharmaceuticals Ltd has gone down to 46.69 per cent as of Dec 2024 from 47.23 per cent as of Mar 2024.
